{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:16:12Z","timestamp":1785597372312,"version":"3.56.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010221","name":"Higher Education Commision, Pakistan","doi-asserted-by":"publisher","award":["20\\u201315760"],"award-info":[{"award-number":["20\\u201315760"]}],"id":[{"id":"10.13039\/501100010221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jacl.2025.02.009","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:52:05Z","timestamp":1739465525000},"page":"451-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends and prevalence of severe hypertriglyceridemia in Pakistan: A 5-year analysis (2019-2023)"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3727-338X","authenticated-orcid":false,"given":"Quratul","family":"Ain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3913-8539","authenticated-orcid":false,"given":"Madeeha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hijab","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Iqbal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5207-2469","authenticated-orcid":false,"given":"Muhammad","family":"Ajmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9399-6078","authenticated-orcid":false,"given":"Fouzia","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jacl.2025.02.009_bib0001","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMcp070061","article-title":"Hypertriglyceridemia","volume":"357","author":"Brunzell","year":"2007","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jacl.2025.02.009_bib0002","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"Cmaj"},{"key":"10.1016\/j.jacl.2025.02.009_bib0003","article-title":"Hypertriglyceridemia: pathophysiology, role of genetics, consequences, and treatment","author":"Subramanian","year":"2024","journal-title":"Endotext South Dartmouth (MA)"},{"key":"10.1016\/j.jacl.2025.02.009_bib0004","article-title":"Management of hypertriglyceridemia","volume":"371","author":"Simha","year":"2020","journal-title":"bmj"},{"key":"10.1016\/j.jacl.2025.02.009_bib0005","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: an endocrine society clinical practice guideline","volume":"97","author":"Berglund","year":"2012","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.jacl.2025.02.009_bib0006","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1586\/erc.12.21","article-title":"Diagnosis and treatment of severe hypertriglyceridemia","volume":"10","author":"Viljoen","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"9","key":"10.1016\/j.jacl.2025.02.009_bib0007","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9149(99)00209-X","article-title":"Epidemiology of hypertriglyceridemia and cardiovascular disease","volume":"83","author":"Austin","year":"1999","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.jacl.2025.02.009_bib0008","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/00325481.2016.1243005","article-title":"Hypertriglyceridemia: the importance of identifying patients at risk","volume":"128","author":"Kushner","year":"2016","journal-title":"Postgrad Med"},{"issue":"1","key":"10.1016\/j.jacl.2025.02.009_bib0009","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.acvdsp.2018.10.261","article-title":"Big data and severe hypertriglyceridemia: prevalence in 297,909 individuals","volume":"11","author":"Ferri\u00e8res","year":"2019","journal-title":"Arch Cardiovasc Dis Supplements"},{"issue":"6","key":"10.1016\/j.jacl.2025.02.009_bib0010","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacl.2023.09.002","article-title":"Severe hypertriglyceridemia prevalence at a primary care setting in Catalonia, Spain","volume":"17","author":"Ortega","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2025.02.009_bib0011","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s40200-020-00631-z","article-title":"NDSP 05: prevalence and pattern of dyslipidemia in urban and rural areas of Pakistan; a sub analysis from second National Diabetes Survey of Pakistan (NDSP) 2016\u20132017","volume":"19","author":"Basit","year":"2020","journal-title":"J Diabetes Metab Disord"},{"issue":"8","key":"10.1016\/j.jacl.2025.02.009_bib0012","doi-asserted-by":"crossref","first-page":"e22579","DOI":"10.1002\/jcla.22579","article-title":"Prevalence of combined and noncombined dyslipidemia in an Iranian population","volume":"32","author":"Darroudi","year":"2018","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"10.1016\/j.jacl.2025.02.009_bib0013","article-title":"Prevalence of dyslipidemia, hypertension and diabetes among tribal and rural population in a south Indian forested region","volume":"4","author":"Majgi","year":"2024","journal-title":"PLOS Global Public Health"},{"issue":"5","key":"10.1016\/j.jacl.2025.02.009_bib0014","doi-asserted-by":"crossref","first-page":"e96808","DOI":"10.1371\/journal.pone.0096808","article-title":"Prevalence of dyslipidemia in urban and rural India: the ICMR\u2013INDIAB Study","volume":"9","author":"Joshi","year":"2014","journal-title":"PLoS One [Internet]"},{"key":"10.1016\/j.jacl.2025.02.009_bib0015","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ihj.2023.11.266","article-title":"Trends in epidemiology of dyslipidemias in India","volume":"76","author":"Sharma","year":"2024","journal-title":"Indian Heart J"},{"issue":"5","key":"10.1016\/j.jacl.2025.02.009_bib0016","article-title":"Prevalence of dyslipidemia and associated risk factors among adult residents of Shenmu City, China","volume":"16","author":"Gao","year":"2021","journal-title":"PLoS One [Internet]"},{"key":"10.1016\/j.jacl.2025.02.009_bib0017","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.3390\/nu14112321","article-title":"Obesity and dyslipidemia in Chinese adults: a cross-sectional study in Shanghai, China","volume":"14","author":"Zhu","year":"2022","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.jacl.2025.02.009_bib0018","article-title":"Prevalence of dyslipidemia and availability of lipid-lowering medications among primary health care settings in China","volume":"4","author":"Lu","year":"2021","journal-title":"JAMA Netw Open [Internet]"},{"key":"10.1016\/j.jacl.2025.02.009_bib0019","first-page":"1569","volume":"22","author":"Sakboonyarat","year":"2022"},{"issue":"6","key":"10.1016\/j.jacl.2025.02.009_bib0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.artere.2020.11.002","article-title":"Prevalence of hypertriglyceridemia in adults and related cardiometabolic factors. SIMETAP-HTG study","volume":"32","author":"Ruiz-Garc\u00eda","year":"2020","journal-title":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis (English Edition)"},{"issue":"2","key":"10.1016\/j.jacl.2025.02.009_bib0021","doi-asserted-by":"crossref","first-page":"201","DOI":"10.12997\/jla.2023.12.2.201","article-title":"Trends in prevalence of hypertriglyceridemia and related factors in Korean adults: a serial cross-sectional study","volume":"12","author":"Park","year":"2023","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.jacl.2025.02.009_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-017-0511-9","article-title":"Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics","volume":"16","author":"Retterst\u00f8l","year":"2017","journal-title":"Lipids Health Dis"},{"issue":"6","key":"10.1016\/j.jacl.2025.02.009_bib0023","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.amjcard.2010.11.008","article-title":"Prevalence of severe (500 to 2,000 mg\/dl) hypertriglyceridemia in United States adults","volume":"107","author":"Christian","year":"2011","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.jacl.2025.02.009_bib0024","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0889-8553(21)00513-6","article-title":"Hyperlipidemic pancreatitis","volume":"19","author":"Toskes","year":"1990","journal-title":"Gastroenterol Clin North Am"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T02:07:44Z","timestamp":1750817264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1933287425000297"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.02.009","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends and prevalence of severe hypertriglyceridemia in Pakistan: A 5-year analysis (2019-2023)","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}